nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.201	0.421	CbGbCtD
Sitaxentan—CYP2C9—Colchicine—primary biliary cirrhosis	0.175	0.366	CbGbCtD
Sitaxentan—CYP3A4—Colchicine—primary biliary cirrhosis	0.102	0.213	CbGbCtD
Sitaxentan—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00444	0.0581	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.00391	0.0512	CbGpPWpGaD
Sitaxentan—Cyst—Chenodeoxycholic acid—primary biliary cirrhosis	0.00375	0.00839	CcSEcCtD
Sitaxentan—Menorrhagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00339	0.00758	CcSEcCtD
Sitaxentan—Menorrhagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00339	0.00758	CcSEcCtD
Sitaxentan—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00336	0.044	CbGpPWpGaD
Sitaxentan—Cholestasis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0033	0.00739	CcSEcCtD
Sitaxentan—Cholestasis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0033	0.00739	CcSEcCtD
Sitaxentan—Pleural effusion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00327	0.00733	CcSEcCtD
Sitaxentan—Pleural effusion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00327	0.00733	CcSEcCtD
Sitaxentan—Skin ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.00322	0.00721	CcSEcCtD
Sitaxentan—Otitis media—Ursodeoxycholic acid—primary biliary cirrhosis	0.00322	0.00721	CcSEcCtD
Sitaxentan—Otitis media—Chenodeoxycholic acid—primary biliary cirrhosis	0.00322	0.00721	CcSEcCtD
Sitaxentan—Skin ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.00322	0.00721	CcSEcCtD
Sitaxentan—Gout—Colchicine—primary biliary cirrhosis	0.00299	0.00669	CcSEcCtD
Sitaxentan—EDNRA—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.0028	0.0367	CbGpPWpGaD
Sitaxentan—Viral infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00277	0.00621	CcSEcCtD
Sitaxentan—Viral infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00277	0.00621	CcSEcCtD
Sitaxentan—Cellulitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00276	0.00617	CcSEcCtD
Sitaxentan—Cellulitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00276	0.00617	CcSEcCtD
Sitaxentan—Herpes simplex—Ursodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00609	CcSEcCtD
Sitaxentan—Herpes simplex—Chenodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00609	CcSEcCtD
Sitaxentan—Blood bilirubin increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00593	CcSEcCtD
Sitaxentan—Hepatic enzyme increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00593	CcSEcCtD
Sitaxentan—Hepatic enzyme increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00593	CcSEcCtD
Sitaxentan—Blood bilirubin increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00593	CcSEcCtD
Sitaxentan—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00568	CcSEcCtD
Sitaxentan—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00568	CcSEcCtD
Sitaxentan—Eructation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00551	CcSEcCtD
Sitaxentan—Eructation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00551	CcSEcCtD
Sitaxentan—Fluid retention—Ursodeoxycholic acid—primary biliary cirrhosis	0.00238	0.00533	CcSEcCtD
Sitaxentan—Fluid retention—Chenodeoxycholic acid—primary biliary cirrhosis	0.00238	0.00533	CcSEcCtD
Sitaxentan—Vaginal infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00237	0.0053	CcSEcCtD
Sitaxentan—Vaginal infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00237	0.0053	CcSEcCtD
Sitaxentan—Neoplasm—Ursodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00507	CcSEcCtD
Sitaxentan—Neoplasm—Chenodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00507	CcSEcCtD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00216	0.0283	CbGpPWpGaD
Sitaxentan—Sleep disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0021	0.0047	CcSEcCtD
Sitaxentan—Sleep disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0021	0.0047	CcSEcCtD
Sitaxentan—Deafness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00203	0.00455	CcSEcCtD
Sitaxentan—Deafness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00203	0.00455	CcSEcCtD
Sitaxentan—Gastrointestinal haemorrhage—Colchicine—primary biliary cirrhosis	0.00202	0.00453	CcSEcCtD
Sitaxentan—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00449	CcSEcCtD
Sitaxentan—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00449	CcSEcCtD
Sitaxentan—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00428	CcSEcCtD
Sitaxentan—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00428	CcSEcCtD
Sitaxentan—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.0019	0.00425	CcSEcCtD
Sitaxentan—Dehydration—Colchicine—primary biliary cirrhosis	0.00188	0.00422	CcSEcCtD
Sitaxentan—Arthritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00187	0.00419	CcSEcCtD
Sitaxentan—Arthritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00187	0.00419	CcSEcCtD
Sitaxentan—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00417	CcSEcCtD
Sitaxentan—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00417	CcSEcCtD
Sitaxentan—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00185	0.0243	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.00184	0.0241	CbGpPWpGaD
Sitaxentan—Cramp muscle—Colchicine—primary biliary cirrhosis	0.00182	0.00408	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00182	0.00408	CcSEcCtD
Sitaxentan—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00407	CcSEcCtD
Sitaxentan—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00407	CcSEcCtD
Sitaxentan—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.00179	0.00401	CcSEcCtD
Sitaxentan—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.00179	0.00401	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00179	0.004	CcSEcCtD
Sitaxentan—Muscular weakness—Colchicine—primary biliary cirrhosis	0.00179	0.004	CcSEcCtD
Sitaxentan—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00382	CcSEcCtD
Sitaxentan—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00382	CcSEcCtD
Sitaxentan—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00379	CcSEcCtD
Sitaxentan—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00379	CcSEcCtD
Sitaxentan—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00376	CcSEcCtD
Sitaxentan—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00376	CcSEcCtD
Sitaxentan—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.00168	0.00376	CcSEcCtD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.00167	0.0219	CbGpPWpGaD
Sitaxentan—Pancytopenia—Colchicine—primary biliary cirrhosis	0.00166	0.00372	CcSEcCtD
Sitaxentan—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00372	CcSEcCtD
Sitaxentan—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00372	CcSEcCtD
Sitaxentan—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00372	CcSEcCtD
Sitaxentan—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00372	CcSEcCtD
Sitaxentan—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00368	CcSEcCtD
Sitaxentan—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00368	CcSEcCtD
Sitaxentan—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00367	CcSEcCtD
Sitaxentan—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00367	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00367	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00367	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0016	0.00359	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0016	0.00359	CcSEcCtD
Sitaxentan—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00352	CcSEcCtD
Sitaxentan—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00352	CcSEcCtD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00155	0.0202	CbGpPWpGaD
Sitaxentan—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00343	CcSEcCtD
Sitaxentan—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00343	CcSEcCtD
Sitaxentan—Stomatitis—Colchicine—primary biliary cirrhosis	0.00152	0.00341	CcSEcCtD
Sitaxentan—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00339	CcSEcCtD
Sitaxentan—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00339	CcSEcCtD
Sitaxentan—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00337	CcSEcCtD
Sitaxentan—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00337	CcSEcCtD
Sitaxentan—Haematuria—Colchicine—primary biliary cirrhosis	0.00149	0.00333	CcSEcCtD
Sitaxentan—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00147	0.00329	CcSEcCtD
Sitaxentan—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00147	0.00329	CcSEcCtD
Sitaxentan—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00325	CcSEcCtD
Sitaxentan—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00325	CcSEcCtD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.00144	0.0189	CbGpPWpGaD
Sitaxentan—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00321	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00321	CcSEcCtD
Sitaxentan—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00318	CcSEcCtD
Sitaxentan—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00318	CcSEcCtD
Sitaxentan—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.00141	0.0185	CbGpPWpGaD
Sitaxentan—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00314	CcSEcCtD
Sitaxentan—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00314	CcSEcCtD
Sitaxentan—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00314	CcSEcCtD
Sitaxentan—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00314	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.00138	0.00309	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.00138	0.00309	CcSEcCtD
Sitaxentan—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00138	0.00309	CcSEcCtD
Sitaxentan—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00138	0.00309	CcSEcCtD
Sitaxentan—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00308	CcSEcCtD
Sitaxentan—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00308	CcSEcCtD
Sitaxentan—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00306	CcSEcCtD
Sitaxentan—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00306	CcSEcCtD
Sitaxentan—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00305	CcSEcCtD
Sitaxentan—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00305	CcSEcCtD
Sitaxentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00135	0.0176	CbGpPWpGaD
Sitaxentan—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00299	CcSEcCtD
Sitaxentan—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00299	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00297	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00297	CcSEcCtD
Sitaxentan—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00296	CcSEcCtD
Sitaxentan—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00296	CcSEcCtD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.00132	0.0172	CbGpPWpGaD
Sitaxentan—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00131	0.00294	CcSEcCtD
Sitaxentan—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00131	0.00294	CcSEcCtD
Sitaxentan—Eye disorder—Colchicine—primary biliary cirrhosis	0.00131	0.00293	CcSEcCtD
Sitaxentan—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00283	CcSEcCtD
Sitaxentan—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00283	CcSEcCtD
Sitaxentan—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00126	0.00283	CcSEcCtD
Sitaxentan—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00282	CcSEcCtD
Sitaxentan—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00282	CcSEcCtD
Sitaxentan—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00282	CcSEcCtD
Sitaxentan—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00282	CcSEcCtD
Sitaxentan—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00278	CcSEcCtD
Sitaxentan—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00278	CcSEcCtD
Sitaxentan—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00278	CcSEcCtD
Sitaxentan—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00278	CcSEcCtD
Sitaxentan—Alopecia—Colchicine—primary biliary cirrhosis	0.00124	0.00277	CcSEcCtD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.00123	0.0162	CbGpPWpGaD
Sitaxentan—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00276	CcSEcCtD
Sitaxentan—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00276	CcSEcCtD
Sitaxentan—Malnutrition—Colchicine—primary biliary cirrhosis	0.00122	0.00273	CcSEcCtD
Sitaxentan—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00272	CcSEcCtD
Sitaxentan—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00272	CcSEcCtD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.0012	0.0157	CbGpPWpGaD
Sitaxentan—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00119	0.0155	CbGpPWpGaD
Sitaxentan—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00263	CcSEcCtD
Sitaxentan—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00263	CcSEcCtD
Sitaxentan—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00263	CcSEcCtD
Sitaxentan—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00263	CcSEcCtD
Sitaxentan—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00117	0.00262	CcSEcCtD
Sitaxentan—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00261	CcSEcCtD
Sitaxentan—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00261	CcSEcCtD
Sitaxentan—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00256	CcSEcCtD
Sitaxentan—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00256	CcSEcCtD
Sitaxentan—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00255	CcSEcCtD
Sitaxentan—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00255	CcSEcCtD
Sitaxentan—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00254	CcSEcCtD
Sitaxentan—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00254	CcSEcCtD
Sitaxentan—Anaemia—Colchicine—primary biliary cirrhosis	0.00113	0.00252	CcSEcCtD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.00112	0.0147	CbGpPWpGaD
Sitaxentan—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00249	CcSEcCtD
Sitaxentan—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00249	CcSEcCtD
Sitaxentan—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00245	CcSEcCtD
Sitaxentan—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00245	CcSEcCtD
Sitaxentan—Leukopenia—Colchicine—primary biliary cirrhosis	0.00109	0.00244	CcSEcCtD
Sitaxentan—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00241	CcSEcCtD
Sitaxentan—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00241	CcSEcCtD
Sitaxentan—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00106	0.00238	CcSEcCtD
Sitaxentan—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00106	0.00238	CcSEcCtD
Sitaxentan—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00105	0.00236	CcSEcCtD
Sitaxentan—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00105	0.00236	CcSEcCtD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.00103	0.0135	CbGpPWpGaD
Sitaxentan—CYP2C19—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00102	0.0133	CbGpPWpGaD
Sitaxentan—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00228	CcSEcCtD
Sitaxentan—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00228	CcSEcCtD
Sitaxentan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00101	0.0133	CbGpPWpGaD
Sitaxentan—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00227	CcSEcCtD
Sitaxentan—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00227	CcSEcCtD
Sitaxentan—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00101	0.0132	CbGpPWpGaD
Sitaxentan—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000988	0.00221	CcSEcCtD
Sitaxentan—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000988	0.00221	CcSEcCtD
Sitaxentan—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000984	0.0022	CcSEcCtD
Sitaxentan—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000984	0.0022	CcSEcCtD
Sitaxentan—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00098	0.0022	CcSEcCtD
Sitaxentan—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00098	0.0022	CcSEcCtD
Sitaxentan—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000976	0.00218	CcSEcCtD
Sitaxentan—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000974	0.00218	CcSEcCtD
Sitaxentan—Skin disorder—Colchicine—primary biliary cirrhosis	0.000966	0.00216	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.00094	0.0123	CbGpPWpGaD
Sitaxentan—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000932	0.00209	CcSEcCtD
Sitaxentan—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000932	0.00209	CcSEcCtD
Sitaxentan—Hypotension—Colchicine—primary biliary cirrhosis	0.00093	0.00208	CcSEcCtD
Sitaxentan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000928	0.0121	CbGpPWpGaD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000926	0.00207	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000926	0.00207	CcSEcCtD
Sitaxentan—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000921	0.00206	CcSEcCtD
Sitaxentan—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000921	0.00206	CcSEcCtD
Sitaxentan—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000912	0.00204	CcSEcCtD
Sitaxentan—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000912	0.00204	CcSEcCtD
Sitaxentan—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000901	0.00202	CcSEcCtD
Sitaxentan—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000901	0.00202	CcSEcCtD
Sitaxentan—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000894	0.002	CcSEcCtD
Sitaxentan—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000894	0.002	CcSEcCtD
Sitaxentan—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000888	0.00199	CcSEcCtD
Sitaxentan—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000888	0.00199	CcSEcCtD
Sitaxentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000887	0.0116	CbGpPWpGaD
Sitaxentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000884	0.0116	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000884	0.0116	CbGpPWpGaD
Sitaxentan—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000877	0.00196	CcSEcCtD
Sitaxentan—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000877	0.00196	CcSEcCtD
Sitaxentan—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000875	0.00196	CcSEcCtD
Sitaxentan—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000875	0.00196	CcSEcCtD
Sitaxentan—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000872	0.00195	CcSEcCtD
Sitaxentan—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000872	0.00195	CcSEcCtD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000871	0.0114	CbGpPWpGaD
Sitaxentan—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000868	0.00194	CcSEcCtD
Sitaxentan—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000868	0.00194	CcSEcCtD
Sitaxentan—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000865	0.00194	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000859	0.00192	CcSEcCtD
Sitaxentan—Fatigue—Colchicine—primary biliary cirrhosis	0.000858	0.00192	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000854	0.0112	CbGpPWpGaD
Sitaxentan—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000852	0.00191	CcSEcCtD
Sitaxentan—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000852	0.00191	CcSEcCtD
Sitaxentan—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000835	0.00187	CcSEcCtD
Sitaxentan—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000835	0.00187	CcSEcCtD
Sitaxentan—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000831	0.0109	CbGpPWpGaD
Sitaxentan—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000809	0.00181	CcSEcCtD
Sitaxentan—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000809	0.00181	CcSEcCtD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000802	0.0105	CbGpPWpGaD
Sitaxentan—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000795	0.00178	CcSEcCtD
Sitaxentan—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000795	0.00178	CcSEcCtD
Sitaxentan—Urticaria—Colchicine—primary biliary cirrhosis	0.00079	0.00177	CcSEcCtD
Sitaxentan—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000787	0.00176	CcSEcCtD
Sitaxentan—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000787	0.00176	CcSEcCtD
Sitaxentan—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000777	0.00174	CcSEcCtD
Sitaxentan—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000777	0.00174	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000772	0.00173	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000772	0.00173	CcSEcCtD
Sitaxentan—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000771	0.00173	CcSEcCtD
Sitaxentan—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000771	0.00173	CcSEcCtD
Sitaxentan—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000764	0.00171	CcSEcCtD
Sitaxentan—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000764	0.00171	CcSEcCtD
Sitaxentan—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000764	0.00171	CcSEcCtD
Sitaxentan—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000764	0.00171	CcSEcCtD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000749	0.00981	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000737	0.00165	CcSEcCtD
Sitaxentan—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000737	0.00165	CcSEcCtD
Sitaxentan—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000733	0.00164	CcSEcCtD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000719	0.00942	CbGpPWpGaD
Sitaxentan—Asthenia—Colchicine—primary biliary cirrhosis	0.000714	0.0016	CcSEcCtD
Sitaxentan—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00071	0.00159	CcSEcCtD
Sitaxentan—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00071	0.00159	CcSEcCtD
Sitaxentan—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000707	0.00158	CcSEcCtD
Sitaxentan—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000707	0.00158	CcSEcCtD
Sitaxentan—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000681	0.00152	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000673	0.00881	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000659	0.00147	CcSEcCtD
Sitaxentan—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000659	0.00147	CcSEcCtD
Sitaxentan—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000641	0.00144	CcSEcCtD
Sitaxentan—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000641	0.00144	CcSEcCtD
Sitaxentan—EDNRB—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000635	0.00831	CbGpPWpGaD
Sitaxentan—Vomiting—Colchicine—primary biliary cirrhosis	0.000633	0.00142	CcSEcCtD
Sitaxentan—Rash—Colchicine—primary biliary cirrhosis	0.000627	0.0014	CcSEcCtD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000627	0.00821	CbGpPWpGaD
Sitaxentan—Dermatitis—Colchicine—primary biliary cirrhosis	0.000627	0.0014	CcSEcCtD
Sitaxentan—Headache—Colchicine—primary biliary cirrhosis	0.000623	0.0014	CcSEcCtD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000623	0.00816	CbGpPWpGaD
Sitaxentan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000612	0.00801	CbGpPWpGaD
Sitaxentan—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000612	0.00137	CcSEcCtD
Sitaxentan—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000612	0.00137	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000611	0.008	CbGpPWpGaD
Sitaxentan—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000591	0.00132	CcSEcCtD
Sitaxentan—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000591	0.00132	CcSEcCtD
Sitaxentan—Nausea—Colchicine—primary biliary cirrhosis	0.000591	0.00132	CcSEcCtD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000584	0.00764	CbGpPWpGaD
Sitaxentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000583	0.00763	CbGpPWpGaD
Sitaxentan—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000579	0.00759	CbGpPWpGaD
Sitaxentan—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000568	0.00127	CcSEcCtD
Sitaxentan—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000568	0.00127	CcSEcCtD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000568	0.00743	CbGpPWpGaD
Sitaxentan—CYP2C19—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000565	0.0074	CbGpPWpGaD
Sitaxentan—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000564	0.00126	CcSEcCtD
Sitaxentan—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000564	0.00126	CcSEcCtD
Sitaxentan—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000563	0.00126	CcSEcCtD
Sitaxentan—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000563	0.00126	CcSEcCtD
Sitaxentan—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00056	0.00125	CcSEcCtD
Sitaxentan—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00056	0.00125	CcSEcCtD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000536	0.00702	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000531	0.00696	CbGpPWpGaD
Sitaxentan—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000531	0.00119	CcSEcCtD
Sitaxentan—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000531	0.00119	CcSEcCtD
Sitaxentan—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000516	0.00675	CbGpPWpGaD
Sitaxentan—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000515	0.00675	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000515	0.00674	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000503	0.00658	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000482	0.00632	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000482	0.00632	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000454	0.00595	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000449	0.00587	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000445	0.00582	CbGpPWpGaD
Sitaxentan—CYP2C19—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000444	0.00582	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000438	0.00574	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000425	0.00556	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.00042	0.0055	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000418	0.00547	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000406	0.00532	CbGpPWpGaD
Sitaxentan—CYP2C9—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000405	0.0053	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000383	0.00501	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.00038	0.00498	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.00036	0.00471	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000345	0.00452	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000345	0.00452	CbGpPWpGaD
Sitaxentan—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.00034	0.00445	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—AGT—primary biliary cirrhosis	0.00032	0.00419	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000318	0.00417	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000314	0.0041	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000304	0.00398	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000301	0.00394	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000296	0.00388	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000285	0.00373	CbGpPWpGaD
Sitaxentan—CYP2C19—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000277	0.00363	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000274	0.00359	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000259	0.00339	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000256	0.00335	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000251	0.00329	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000239	0.00313	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000233	0.00305	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000229	0.003	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000228	0.00299	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000216	0.00283	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000212	0.00277	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000208	0.00272	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000204	0.00267	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000196	0.00257	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000185	0.00242	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000181	0.00237	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.00018	0.00235	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000171	0.00224	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GGT1—primary biliary cirrhosis	0.000165	0.00217	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000164	0.00215	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000163	0.00214	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000155	0.00203	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000155	0.00203	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GGT1—primary biliary cirrhosis	0.000151	0.00197	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000149	0.00195	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000141	0.00185	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000141	0.00184	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000135	0.00176	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000129	0.0017	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000123	0.00161	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.000123	0.00161	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000118	0.00154	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000116	0.00152	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LBR—primary biliary cirrhosis	0.000114	0.00149	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000112	0.00147	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LBR—primary biliary cirrhosis	0.000104	0.00136	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	9.94e-05	0.0013	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HIF1A—primary biliary cirrhosis	9.74e-05	0.00128	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AGT—primary biliary cirrhosis	9.71e-05	0.00127	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL10—primary biliary cirrhosis	9.65e-05	0.00126	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP3—primary biliary cirrhosis	8.8e-05	0.00115	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—TYK2—primary biliary cirrhosis	8.79e-05	0.00115	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CD80—primary biliary cirrhosis	8.6e-05	0.00113	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL5—primary biliary cirrhosis	8.3e-05	0.00109	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—OGDH—primary biliary cirrhosis	8.23e-05	0.00108	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	8.05e-05	0.00105	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	7.5e-05	0.000982	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	7.42e-05	0.000972	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PDHX—primary biliary cirrhosis	7.34e-05	0.00096	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TYK2—primary biliary cirrhosis	7.26e-05	0.00095	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HIF1A—primary biliary cirrhosis	6.97e-05	0.000913	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AGT—primary biliary cirrhosis	6.95e-05	0.000909	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCB4—primary biliary cirrhosis	6.9e-05	0.000903	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—DLAT—primary biliary cirrhosis	6.9e-05	0.000903	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	6.85e-05	0.000896	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	6.77e-05	0.000886	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	6.69e-05	0.000876	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	6.35e-05	0.000831	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	6.29e-05	0.000823	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	6.29e-05	0.000823	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CD80—primary biliary cirrhosis	6.15e-05	0.000806	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	5.79e-05	0.000758	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP9—primary biliary cirrhosis	5.72e-05	0.000748	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NFKB1—primary biliary cirrhosis	5.66e-05	0.00074	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	5.65e-05	0.00074	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TYK2—primary biliary cirrhosis	5.2e-05	0.00068	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	5.15e-05	0.000675	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	4.95e-05	0.000648	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	4.41e-05	0.000577	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	4.4e-05	0.000576	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	4.15e-05	0.000543	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	4.15e-05	0.000543	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NUP210—primary biliary cirrhosis	4.14e-05	0.000543	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—primary biliary cirrhosis	4.09e-05	0.000536	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.05e-05	0.00053	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	4.01e-05	0.000525	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCG2—primary biliary cirrhosis	3.85e-05	0.000504	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	3.78e-05	0.000495	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	3.51e-05	0.00046	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	3.38e-05	0.000442	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CTGF—primary biliary cirrhosis	3.31e-05	0.000433	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GOT2—primary biliary cirrhosis	3.28e-05	0.000429	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	3.08e-05	0.000403	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	3.01e-05	0.000395	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	2.99e-05	0.000391	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GOT1—primary biliary cirrhosis	2.83e-05	0.00037	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GGT1—primary biliary cirrhosis	2.83e-05	0.00037	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	2.58e-05	0.000338	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	2.58e-05	0.000338	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARGC1A—primary biliary cirrhosis	2.52e-05	0.00033	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	2.49e-05	0.000326	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	2.32e-05	0.000303	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	2.29e-05	0.0003	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	1.99e-05	0.00026	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	1.97e-05	0.000258	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AGT—primary biliary cirrhosis	1.96e-05	0.000257	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	1.79e-05	0.000234	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	1.7e-05	0.000223	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	1.7e-05	0.000223	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	1.51e-05	0.000198	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—primary biliary cirrhosis	1.5e-05	0.000197	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	1.37e-05	0.00018	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	1.18e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	9.05e-06	0.000118	CbGpPWpGaD
